Evaluation of Biological Treatment of Pharmaceutical Wastewater with PAC (Powdered Activated Carbon) Addition. Volume 2. Appendices

摘要

A lack of information on applicable removal technologies for total chemical oxygen demand (TCOD) prevented promulgation of best available technology economically achievable (BAT) limitations and new source performance standards (NSPS) for TCOD for pharmaceutical manufacturing plants in 1983 (EPA/440/1-83/084). Therefore, in 1984 EPA conducted a pilot plant study of activated carbon treatment technologies utilizing pharmaceutical wastewaters from a manufacturing plant that produces fermentation products (Subcategory A) and chemical synthesis products (Subcategory C). The purposes of the study were to: (1) attempt to find the cause of the formation of the VFMLS; (2) generate additional research data for TCOD removal from pharmaceutical wastewater using the PACT process; (3) evaluate the efficiency of PACT in removing specific organics; (4) evaluate the effectiveness of PACT in reducing effluent aquatic toxicity; and, (5) evaluate the use of a selector to improve the settleability of the mixed liquor. One control unit, two PACT characteristics of the mixed liquor suspended solids were operated.